Home/Hedge Fund Intelligence/Biomarin Pharmaceutical Inc
Nasdaq: BMRNStockForm 13F30 Jun 2026

Hedge funds that hold Biomarin Pharmaceutical Inc Nasdaq: BMRN

CUSIP 09061G101 · who reports it, how much, and how much it matters to them

45 of the 720 hedge fund managers we track reported shares of Biomarin Pharmaceutical Inc (Nasdaq: BMRN) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to Viking Global Investors, at USD 436m. The manager with the most riding on it is Boone Capital Management, where it is 7.8% of the reported book.

Managers reporting it45of 720 we track
Value they reportUSD 1.2bnshares only, 30 Jun 2026
Funds they run513with a file on PPLI.com
Largest positionUSD 436mViking Global Investors
Typical weight0.1%median share of a manager's book
Heaviest weight7.8%Boone Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

45 managers, USD 1.2bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Biomarin Pharmaceutical Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Viking Global Investors4 funds on PPLI.comUSD 436m1.2%
2Deep Track Capital1 fund on PPLI.comUSD 189m2.8%
3Millennium Management6 funds on PPLI.comUSD 119m0.0%
4Citadel Advisors32 funds on PPLI.comUSD 64m0.0%
5Balyasny Asset Management25 funds on PPLI.comUSD 60m0.1%
6Hudson Bay Capital Management8 funds on PPLI.comUSD 47m0.1%
7Palo Alto Investors6 funds on PPLI.comUSD 39m5.4%
8Eagle Health Investments1 fund on PPLI.comUSD 36m5.9%
9Boone Capital Management1 fund on PPLI.comUSD 33m7.8%
10Renaissance Technologies13 funds on PPLI.comUSD 26m0.0%
11Freestone Grove Partners1 fund on PPLI.comUSD 21m0.1%
12Sofinnova Investments1 fund on PPLI.comUSD 21m1.1%
13Sphera Funds Management1 fund on PPLI.comUSD 19m2.5%
14Walleye Capital8 funds on PPLI.comUSD 16m0.1%
15Bridgewater Associates45 funds on PPLI.comUSD 16m0.1%
16Redmile Group10 funds on PPLI.comUSD 15m1.0%
17Eversept Partners3 funds on PPLI.comUSD 14m0.7%
18Capital Fund Management S.A.12 funds on PPLI.comUSD 13m0.1%
19Engineers Gate Manager1 fund on PPLI.comUSD 10m0.1%
20Squarepoint Ops7 funds on PPLI.comUSD 6.1m0.0%
21Schonfeld Strategic Advisors30 funds on PPLI.comUSD 5.9m0.0%
22Edgestream Partners5 funds on PPLI.comUSD 5.8m0.2%
23Marshall Wace LLP84 funds on PPLI.comUSD 5.6m0.0%
24D. E. Shaw & Co.15 funds on PPLI.comUSD 5.3m0.0%
25Persistent Asset Partners10 funds on PPLI.comUSD 4.6m1.4%
26Boothbay Fund Management2 funds on PPLI.comUSD 3.7m0.0%
27Atom Investors1 fund on PPLI.comUSD 3m0.3%
28Two Sigma Investments35 funds on PPLI.comUSD 1.6m0.0%
29Campbell & Company Investment Adviser8 funds on PPLI.comUSD 1.4m0.1%
30Verition Fund Management3 funds on PPLI.comUSD 1.3m0.0%
31Greenland Capital Management1 fund on PPLI.comUSD 1.1m0.1%
32The Quarry1 fund on PPLI.comUSD 1m0.1%
33Aquatic Capital Management3 funds on PPLI.comUSD 986,0000.0%
34Voleon Capital Management13 funds on PPLI.comUSD 943,0000.0%
35CM Management1 fund on PPLI.comUSD 858,0000.5%
36Gamco Asset Management1 fund on PPLI.comUSD 744,0000.0%
37Holocene Advisors2 funds on PPLI.comUSD 668,0000.0%
38Capstone Investment Advisors25 funds on PPLI.comUSD 559,0000.0%
39CIBC Asset Management69 funds on PPLI.comUSD 339,0000.0%
40Prelude Capital Management9 funds on PPLI.comUSD 332,0000.0%
41Landscape Capital Management4 funds on PPLI.comUSD 320,0000.0%
42Oxford Asset Management LLP2 funds on PPLI.comUSD 313,0000.2%
43ISAM Funds (UK)1 fund on PPLI.comUSD 309,0000.2%
44Entrypoint Capital1 fund on PPLI.comUSD 299,0000.1%
45Summit Global Investments1 fund on PPLI.comUSD 1,8690.1%
Next: where it matters most
Where it matters most

For Boone Capital Management it is 7.8% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Boone Capital ManagementUSD 33m7.8%
2Eagle Health InvestmentsUSD 36m5.9%
3Palo Alto InvestorsUSD 39m5.4%
4Deep Track CapitalUSD 189m2.8%
5Sphera Funds ManagementUSD 19m2.5%
6Persistent Asset PartnersUSD 4.6m1.4%
7Viking Global InvestorsUSD 436m1.2%
8Sofinnova InvestmentsUSD 21m1.1%
9Redmile GroupUSD 15m1.0%
10Eversept PartnersUSD 14m0.7%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Biomarin Pharmaceutical Inc

What is the ticker symbol of Biomarin Pharmaceutical Inc?

Biomarin Pharmaceutical Inc trades under the symbol BMRN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09061G101.

Which hedge funds own Biomarin Pharmaceutical Inc (Nasdaq: BMRN)?

45 of the 720 hedge fund managers PPLI.com tracks reported Biomarin Pharmaceutical Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Viking Global Investors (USD 436m), Deep Track Capital (USD 189m), Millennium Management (USD 119m), Citadel Advisors (USD 64m) and Balyasny Asset Management (USD 60m).

How many hedge funds hold Biomarin Pharmaceutical Inc?

45 managers in our coverage reported it, and between them they run 513 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Biomarin Pharmaceutical Inc?

Boone Capital Management, where the position was 7.8% of the reported 13F book at 30 June 2026.

Does this show who is short Biomarin Pharmaceutical Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Biomarin Pharmaceutical Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.